Biktarvy
HIV treatment
2 conceptsBiktarvy is Gilead's single-tablet HIV-1 treatment regimen combining bictegravir, emtricitabine, and tenofovir alafenamide.
ProductsGilead Sciences
Gilead Sciences product analyses
A tighter look at the products that matter most to Gilead Sciences, along with the free, open, decentralized, or cooperative alternatives already creating pricing pressure and the original disruption concepts that could widen that pressure further.
Products
Where the moat actually touches users
These pages zoom into the products and services that matter most to each company, the alternatives already nibbling at them, and 4 structured disruption concepts across the current product set.
4 disruption concepts tracked0 documented exceptions
Trodelvy
Oncology antibody-drug conjugate
2 conceptsTrodelvy is Gilead's sacituzumab govitecan-hziy therapy, a Trop-2-directed antibody-drug conjugate used in certain metastatic breast-cancer settings.
Paper trail
Company-level source stack
These sources shaped the scoring and writing. The site is opinionated, but it should not behave like it is improvising facts in a dark room.
Gilead Sciences Investor Relations
Gilead Sciences · investor relations
Primary investor-relations portal for company financial releases and reports.
Reviewed 2026-05-25
Gilead Sciences 2024 Form 10-K
Gilead Sciences · annual report
Annual-report source for product sales context, business risks, HIV franchise strength, oncology products, and competitive/regulatory disclosures.
Reviewed 2026-05-25
Gilead Medicines
Gilead Sciences · product page
Company product list used to verify Biktarvy and Trodelvy as Gilead medicines.
Reviewed 2026-05-25
Gilead Sciences Market Cap
CompaniesMarketCap.com · market data
Market-cap reference supplied in the queued manifest.
Reviewed 2026-05-25
Gilead Sciences Stock Price and Financial Metrics
StockAnalysis · market data
Market-data source for approximate market capitalization, P/E ratio, revenue, and company financial snapshot near the review date.
Reviewed 2026-05-25